You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Random Number Generation for High Performance Computing
SBC: Silicon Informatics, Inc. Topic: A10AT012Highly scalable parallel random number generators (RNGs) will be developed, evaluated and implemented for use in high performance computing on thousands of multi-core processors and general purpose graphics processing units. The main contributions are: (a) design and implementation of new parallel test methods that capture the inter-stream correlations exhibited in practice and complement the curr ...
STTR Phase I 2010 Department of DefenseArmy -
On-Chip Passive Phase-Locking for High Coherent Power, Mid-IR Quantum Cascade Lasers
SBC: INTRABAND, LLC Topic: A10AT007The technical objectives of this proposal are: 1) the design of 8 micron-emitting active-photonic-crystal (APC) quantum-cascade (QC) lasers by using passive phase-locking in a monolithic structure in order to achieve multiwatt-range, diffraction-limited powers; and 2) the development of the key fabrication steps for realizing the proposed APC QC laser. Deep-well (DW) QC lasers will be used in the ...
STTR Phase I 2010 Department of DefenseArmy -
Benign, Inexpensive Simulant for testing of Biological Standoff Sensors
SBC: Orono Spectral Solutions Inc. Topic: A10AT017The goal of this Phase I proposal is to develop a synthetic, low cost, and benign simulant for biowarfare agents (BWA) to be used in the testing of standoff sensors. Orono Spectral Solutions Inc. (OSS) has performed preliminary work leading to the identification of benign ingredients that, when combined in a predefined mass ratio, mimic UV-Vis and infrared signatures of BG spores. This work was pe ...
STTR Phase I 2010 Department of DefenseArmy -
High surface-area, mesoporous oxide adsorbent sampling system.
SBC: Orono Spectral Solutions Inc. Topic: A10AT018The overall goal of this Phase I project is to demonstrate the feasibility of an infrared transparent, micro-fluidic sampling system that will lead to a field-deployable detection system capable of detecting low ppb levels of chemical warfare (CW) agents in water. To accomplish this goal, the proposed detection system will combine high surface area, organically modified mesoporous oxide absorptiv ...
STTR Phase I 2010 Department of DefenseArmy -
GalT-KO Pigs Expressing Primate CD47 to Facilitate Organ Xenografts
SBC: MINITUBE OF AMERICA Topic: NIAIDDESCRIPTION (provided by applicant): Xenotransplantation with pig organs offers the best near term hope for satisfying the limitation imposed by shortage of human organs. Although hyperacute rejection of pig organs in primate recipients has been overcome by the production of (-1,3-galactosyltransferase knockout (GalT-KO) pigs, experiments to date with GalT-KO organs strongly suggest that clinical ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Survey and Test Platform for Use in Underserved Populations
SBC: ADVANCED MEDICAL ELECTRONICS CORP Topic: NEIDESCRIPTION (provided by applicant): Advanced Medical Electronics Corp, in collaboration with the Johns Hopkins University School of Medicine, proposes to develop a hardware/software platform suitable for administering a variety of tests and survey instruments to underserved populations in settings that can range from living rooms to libraries, community centers to nursing homes, and from inner ci ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Development and Testing of Recombinant Clostridia for Cancer Therapy
SBC: SGM BIOTECH, INC. Topic: NCRRDESCRIPTION (provided by applicant): This STTR application is to develop and test for eventual clinical use a new strategy for tumor specific anticancer drug delivery. The technology, Clostridia-directed enzyme prodrug therapy, or CDEPT, exploits the fact that certain non-pathogenic bacteria of the Clostridia genus, which only grow in the absence of oxygen (hypoxia), colonize the hypoxic and necr ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Bioengineering Approaches to Energy Balance and Obesity
SBC: MUVE, INC. Topic: NIDDKDESCRIPTION (provided by applicant): It is uniformly recognized that sedentariness - the sitting disease - is bad for the health of the nation. The solution to reversing sedentariness involves devising and disseminating real-world solutions to promote day-long physical activity and help people who want to, to lose weight and improve their blood glucose, lipids and blood pressure. The Gruve is ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Potent Antifolates as New Therapeutics for MRSA
SBC: Promiliad Biopharma Incorporated Topic: NIAIDDESCRIPTION (provided by applicant): This Phase II STTR proposal describes a collaborative effort between researchers in the Department of Pharmaceutical Sciences at the University of Connecticut and Promiliad Biopharma to develop efficacious antibiotics targeting both methicillin-resistant strains of Staphylococcus aureus (MRSA) and Streptococcus pyogenes. We have recently completed a Phase I STT ...
STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
A Human Intraepithelial Tumor Microenvironment Assay
SBC: Stratatech Corporation Topic: NCIDESCRIPTION (provided by applicant): The goal of this STTR project is to develop innovative human tumor microenvironment (TM) assays for use as screening tools in the identification of new anti-tumor therapeutics. Novel assay technologies are needed for the discovery of new drugs, and combinations of drugs currently in clinical use, that are effective in the prevention and treatment of cancer. Thi ...
STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health